Last reviewed: June 19, 2026
Last updated: June 19, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Wegovy®, works by slowing stomach emptying and reducing hunger signals in the brain—but finding the right dose is personal. Most people begin at 0.25 mg weekly, with increases every four weeks until reaching an effective maintenance level. PlexusDx provides access to compounded semaglutide from licensed 503A pharmacies, allowing you to find your optimal dose without worrying about escalating costs.
Understanding Semaglutide Dosing Range and Starting Points
Semaglutide injections typically start at 0.25 mg per week—a low dose designed to let your body adapt and reduce nausea. This introductory phase usually lasts four weeks, after which your provider may recommend increasing to 0.5 mg weekly. The dosing pattern continues incrementally, moving through 1 mg, 1.7 mg, and potentially reaching 2.4 mg weekly depending on your individual tolerance and weight loss response.
Not everyone reaches the maximum dose, and that's medically appropriate. Clinical data shows that meaningful weight loss often occurs at doses between 1 mg and 2 mg weekly for many patients. Your healthcare provider will evaluate your progress, side effects, and goals to determine whether continuing to increase is right for you or whether stabilizing at a lower dose makes the most sense.
The four-week interval between dose increases allows your system to establish a baseline and gives your provider clear information about how well each dose is working. Rushing through dose levels increases the risk of unmanageable nausea and vomiting, which can make the treatment experience unpleasant and lead to discontinuation.
How Your Body Responds: Titration Schedules and Timeline
A standard titration schedule spans 16 to 20 weeks to reach a therapeutic maintenance dose. During weeks 1–4, you inject 0.25 mg; weeks 5–8 increase to 0.5 mg; weeks 9–12 move to 1 mg; weeks 13–16 advance to 1.7 mg; and weeks 17+ may include 2.4 mg if your provider determines it's appropriate. This gradual approach mirrors how the original Wegovy® clinical trials were designed, allowing your gastrointestinal system and appetite-control pathways to adjust without overwhelming your body.
Some patients experience nausea even at the lowest dose and may benefit from a slower titration—taking an extra week or two at each level before advancing. Others feel comfortable progressing on schedule and find that side effects resolve naturally as their body acclimate. Your individual response depends on factors like baseline stomach sensitivity, medication history, and how your GLP-1 and GIPR receptors function—information PlexusDx can explore through the Precision Peptide Genetic Test.
Reaching your maintenance dose doesn't mean stopping there. Once you've found a dose that produces steady weight loss and manageable side effects, you typically continue that same amount weekly. Many patients maintain results on 1.7 mg or 2.4 mg indefinitely, though some may eventually reduce to a lower holding dose after reaching their goal weight.
Why Dose Matters: Efficacy and Individual Variation in Weight Loss
Research published in major obesity journals shows that higher doses of semaglutide generally produce greater weight loss, but the relationship isn't linear for everyone. In pivotal trials, patients receiving 2.4 mg weekly lost an average of 15% of their body weight over 68 weeks, while those on 1.7 mg averaged approximately 12% loss. However, these are population averages—individual responses vary based on genetics, metabolism, and how well your body's peptide signaling pathways respond to GLP-1 stimulation.
Some patients achieve their weight loss goals at 1 mg or 1.7 mg and experience unnecessary side effects if pushed to 2.4 mg. Others may need the full dose to see meaningful results. This is where personalized medicine matters: your provider should tailor dosing based on your outcomes, side effect profile, and long-term sustainability rather than forcing everyone to a standardized maximum.
Genetics play a measurable role in how you respond to semaglutide. Variants in the GLP1R gene (like rs6923761) and GIPR gene (like rs1800437) influence how effectively the medication signals to your appetite-control centers. The Precision Peptide Genetic Test from PlexusDx maps these pathways across 14 mechanisms and 49 peptides, giving your provider insight into your individual peptide biology and helping guide smarter dosing decisions.
Accessing Semaglutide Without the Brand-Name Price Tag
PlexusDx compounded semaglutide injections start at $149 per month—a fraction of brand-name Wegovy®'s typical $1,400+ monthly cost. Because PlexusDx works with licensed 503A compounding pharmacies across all 50 states, medications are customized to your needs and don't require insurance approval or membership fees. Your dose may increase through the titration schedule, but PlexusDx's pricing structure means your monthly cost stays flat: your dose goes up, your price won't.
If you're using a Health Savings Account or Flexible Spending Account, compounded semaglutide from PlexusDx is HSA/FSA eligible, allowing you to use pretax dollars for treatment. This further reduces out-of-pocket costs compared to paying for brand-name medications with after-tax income. For patients without insurance coverage for GLP-1 therapy, PlexusDx provides a straightforward, predictable alternative.
After your first month of treatment, you have the option to add the Precision Peptide Genetic Test for $99. This single add-on test can reveal whether your genetic profile suggests you'll respond well to semaglutide monotherapy or whether a dual-compound approach (like GLP-Squared, combining semaglutide and tirzepatide) might optimize your outcomes. Genetic insight takes the guesswork out of finding your ideal dose and medication match.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What happens if I can't tolerate higher doses of semaglutide?
Staying at a lower dose is completely acceptable if you're achieving weight loss and managing side effects comfortably. Many patients reach their goals on 1 mg or 1.7 mg weekly. If nausea becomes severe, discuss dose reduction or slower titration with your provider—the goal is sustainable, long-term treatment, not maximum dose.
How quickly will I see weight loss results on semaglutide?
Most people notice reduced hunger and appetite within 1–2 weeks of starting, but measurable weight loss typically appears after 4–8 weeks of consistent injections. Significant results accumulate over 16–20 weeks as your dose reaches therapeutic levels. Clinical trials showed steady weight loss continuing through week 68, with effects stabilizing at maintenance doses.
Can I start semaglutide at a higher dose to speed up results?
No—starting higher than 0.25 mg dramatically increases nausea, vomiting, and gastrointestinal side effects without improving weight loss speed. The gradual titration schedule is evidence-based and optimizes both safety and long-term adherence. Rushing the dose schedule typically leads to discontinuation rather than faster success.
Does PlexusDx charge more if my dose increases during titration?
No. PlexusDx compounded semaglutide is priced flat at $149 per month regardless of dose level. Your dose may increase from 0.25 mg to 2.4 mg over four months, but your monthly cost remains the same—your dose goes up, your price won't.
How does the Precision Peptide Genetic Test help with semaglutide dosing?
The test identifies your genetic variants in GLP1R, GIPR, FTO, and MC4R pathways, revealing how your body naturally processes appetite signals. This information helps your provider predict whether you'll respond robustly to semaglutide alone, need a higher dose, or might benefit from dual-therapy compounds like GLP-Squared. Genetic insight personalizes your treatment plan from the start.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Where to Inject Zepbound: Your Comprehensive Guide for Safe and Effective Use
Starting Your Journey: What’s the Lowest Dose of Ozempic and Why It Matters for Your Health